DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Williams B, MacDonald TM, Morant SV. et al.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY‑2): a randomised, doubleblind, crossover trial.
Lancet 2015;
386: 2059-2068
We do not assume any responsibility for the contents of the web pages of other providers.